Dexrazoxane and Tacrolimus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dexrazoxane (dexrazoxane hydrochloride) and Tacrolimus (tacrolimus). Common drug interactions include neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Dexrazoxane and Tacrolimus. It is created by eHealthMe based on reports of 70 people who take the same drugs from the FDA, and is updated regularly.

What is Dexrazoxane?

Dexrazoxane has active ingredients of dexrazoxane hydrochloride. eHealthMe is studying from 1,141 Dexrazoxane users. Check the latest studies of Dexrazoxane.

What is Tacrolimus?

Tacrolimus has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 116,160 Tacrolimus users. Check the latest studies of Tacrolimus.

On Jul, 09, 2026

70 people who take Dexrazoxane and Tacrolimus together, and have interactions are studied.

Dexrazoxane and Tacrolimus drug interactions.

What are the common drug interactions of Dexrazoxane and Tacrolimus, by gender? *:

female:

n/a

male:

Neutropenia (an abnormally low number of neutrophils)
Renal impairment (severely reduced kidney function)
Device related infection
Sepsis (a severe blood infection that can lead to organ failure and death)
Epstein-barr virus associated lymphoproliferative disorder (lymphocytes are produced in excessive quantities associated with epstein-barr virus)
Abdominal pain
Burkitt's lymphoma (cancer of the lymphatic system)
Bacterial sepsis
Lymphadenopathy (disease or enlargement of lymph nodes)
Thrombocytopenia (decrease of platelets in blood)

What are the common drug interactions of Dexrazoxane and Tacrolimus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Thrombocytopenia (decrease of platelets in blood)
Neutropenia (an abnormally low number of neutrophils)
Febrile neutropenia (fever with reduced white blood cells)
Mucosal inflammation (infection of mucous membrane)
Venoocclusive disease (small veins in the liver are obstructed)

10-19:

Staphylococcal bacteraemia (a bacterial infection of blood)
Epstein-barr viraemia
Lymphoproliferative disorder (a medical condition in which the immune system makes too many white blood cells)
Renal failure (kidney dysfunction)
Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Sepsis (a severe blood infection that can lead to organ failure and death)
Device related infection
Epstein-barr virus associated lymphoproliferative disorder (lymphocytes are produced in excessive quantities associated with epstein-barr virus)
Abdominal pain
Burkitt's lymphoma (cancer of the lymphatic system)

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

Immunodeficiency Disorders: 42 people, 60.00%
Burkitt's Lymphoma (cancer of the lymphatic system): 36 people, 51.43%
Ill-Defined Disorder: 8 people, 11.43%
Epstein-Barr Virus Associated Lymphoproliferative Disorder (lymphocytes are produced in excessive quantities associated with epstein-barr virus): 7 people, 10.00%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 4 people, 5.71%

* Approximation only. Some reports may have incomplete information.

Do you take Dexrazoxane and Tacrolimus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously